246 results on '"Krumholz, Harlan M."'
Search Results
52. Safety and Efficacy of Inferior Vena Cava Filters in Patients at Risk of Pulmonary Embolism: A Systematic Review and Meta-Analysis
53. Trends in Acute Myocardial Infarction in Young Patients and Differences by Sex and Race, 2001 to 2010
54. Temporal Trends in Gender of Principal Investigators and Patients in Cardiovascular Clinical Trials
55. Update on the American Board of Internal Medicine Maintenance of Certification Program: A Report of the American College of Cardiology’s Educational Quality Review Board
56. Trends in Hospitalization Rates and Outcomes of Endocarditis Among Medicare Beneficiaries
57. The Next Era of JACC
58. Cardiac Status Among Heart Failure Patients With Implantable Cardioverter Defibrillators Before, During, and After COVID-19 Lockdown
59. Discontinuation of Antihyperglycemic Therapy After Acute Myocardial Infarction: Medical Necessity or Medical Error?
60. Body Mass Index and Mortality in Acute Myocardial Infarction Patients
61. Recent Trends in Hospitalization for Acute Myocardial Infarction
62. Patterns and Loss of Sexual Activity in the Year Following Hospitalization for Acute Myocardial Infarction (a United States National Multisite Observational Study)
63. Building Hospital Management Capacity to Improve Patient Flow for Cardiac Catheterization at a Cardiovascular Hospital in Egypt
64. 5 - Clinical Decision-Making in Cardiology
65. SEX DIFFERENCES IN TREATMENT STRATEGIES FOR PULMONARY EMBOLISM IN OLDER ADULTS: THE SERIOUS-PE STUDY
66. OPTIMIZING PHENOTYPING ALGORITHMS FOR IDENTIFYING PULMONARY EMBOLISM IN ELECTRONIC DATABASES: THE MULTICENTER PE-EHR+ STUDY
67. LIPID PROFILE AND LIPID-LOWERING THERAPY AMONG ACUTE MYOCARDIAL INFARCTION PATIENTS WITHOUT PREVIOUS ATHEROSCLEROTIC CARDIOVASCULAR DISEASE
68. UTILIZATION OF LIPID-LOWERING THERAPY AND LDL-CHOLESTEROL IN PATIENTS WITH PRIOR ATHEROSCLEROTIC CARDIOVASCULAR DISEASE PRESENTING WITH ACUTE MYOCARDIAL INFARCTION
69. COMPARATIVE CARDIOVASCULAR EFFECTIVENESS OF ANTI-HYPERGLYCEMIC AGENTS INITIATED AS SECOND-LINE THERAPY IN TYPE 2 DIABETES: A LARGE-SCALE, MULTINATIONAL, FEDERATED TARGET TRIAL EMULATION IN THE LEGEND-T2DM STUDY
70. HYPERTENSION EXCESS MORTALITY AND YEARS OF POTENTIAL LIFE LOST IN BLACK AMERICANS: A TWO-DECADE ANALYSIS INCLUDING THE COVID-19 PANDEMIC
71. EXCESS ISCHEMIC HEART DISEASE MORTALITY AND YEARS OF POTENTIAL LIFE LOST AMONG THE BLACK POPULATION: A TWO-DECADE ANALYSIS INCLUDING THE COVID-19 PANDEMIC
72. Variation in Reader-Reported Severity of Paradoxical Low-Flow Low-Gradient Aortic Stenosis
73. ACCF/AHA 2011 Health Policy Statement on Therapeutic Interchange and Substitution: A Report of the American College of Cardiology Foundation Clinical Quality Committee
74. Cardiac Care for Older Adults: Time for a New Paradigm
75. Angina frequency after myocardial infarction and quality of life in older versus younger adults: The Prospective Registry Evaluating Myocardial Infarction: Event and Recovery study
76. Racial Disparities in Health Literacy and Access to Care Among Patients With Heart Failure
77. Effect of Living Alone on Patient Outcomes After Hospitalization for Acute Myocardial Infarction
78. Association of STEMI regionalization of care with de facto NSTEMI regionalization
79. Beyond insurance coverage: Usual source of care in the treatment of hypertension and hypercholesterolemia. Data from the 2003-2006 National Health and Nutrition Examination Survey
80. Variation in Hospital Mortality Rates for Patients With Acute Myocardial Infarction
81. Importance of Measuring Glycosylated Hemoglobin in Patients With Myocardial Infarction and Known Diabetes Mellitus
82. Cerebral Venous Sinus Thrombosis in the U.S. Population, After Adenovirus-Based SARS-CoV-2 Vaccination, and After COVID-19
83. SARS-CoV-2 Infection Hospitalization Rate and Infection Fatality Rate Among the Non-Congregate Population in Connecticut
84. Trends and Predictors of Use of Digital Health Technology in the United States
85. The Door-to-Balloon Alliance for Quality: Who Joins National Collaborative Efforts and Why?
86. Door-to-Balloon Times in Hospitals Within the Get-With-The-Guidelines Registry After Initiation of the Door-to-Balloon (D2B) Alliance
87. Association of Door-to-Balloon Time and Mortality in Patients ≥65 Years With ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
88. Longitudinal Systemic Bevacizumab Therapy Produces Cost Savings and Improves Quality-Adjusted Life Expectancy in the Care of Patients with Hereditary Hemorrhagic Telangiectasia with Moderate-to-Severe Bleeding
89. ACC/AHA 2008 Statement on Performance Measurement and Reperfusion Therapy: A Report of the ACC/AHA Task Force on Performance Measures (Work Group to Address the Challenges of Performance Measurement and Reperfusion Therapy)
90. ACC/AHA 2008 Performance Measures for Adults With ST-Elevation and Non–ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures (Writing Committee to Develop Performance Measures for ST-Elevation and Non–ST-Elevation Myocardial Infarction) Developed in Collaboration With the American Academy of Family Physicians and American College of Emergency Physicians Endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation, Society for Cardiovascular Angiography and Interventions, and Society of Hospital Medicine
91. Standards for Measures Used for Public Reporting of Efficiency in Health Care: A Scientific Statement From the American Heart Association Interdisciplinary Council on Quality of Care and Outcomes Research and the American College of Cardiology Foundation
92. Regional Variation in Cardiac Catheterization Appropriateness and Baseline Risk After Acute Myocardial Infarction
93. A Campaign to Improve the Timeliness of Primary Percutaneous Coronary Intervention: Door-to-Balloon: An Alliance for Quality
94. 2007 Focused Update of the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction
95. The Relationship Between Anemia, Change in Hematocrit Over Time and Change in Health Status in Patients With Heart Failure After Myocardial Infarction
96. ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices) Developed in Collaboration With the American Association for Thoracic Surgery and Society of Thoracic Surgeons
97. ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices) Developed in Collaboration With the American Association for Thoracic Surgery and Society of Thoracic Surgeons
98. Regulation of Cardiovascular Therapies During the COVID-19 Public Health Emergency
99. The Year in Epidemiology, Health Services Research, and Outcomes Research
100. ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction) Developed in Collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons Endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.